Allergen Immunotherapy Remains Effective

JULY 01, 2005

Patients undergoing a 3-to 5-year course of allergen immunotherapy shots still see the benefits for >5 years after stopping treatment. The findings are based on a survey of immunotherapy patients in Tennessee. The study looked at the return of allergy symptoms in 2 groups of patients—126 had finished immunotherapy 1 to 4 years prior and 167 had completed the regimen 5 to 12 years prior.

"We did not find any major differences in these 2 [groups]—those being off shots 1 to 4 years and those being off shots 5 or more years,"said lead investigator John M. Fahrenholz, MD.

The results of the study showed, in the 1-to 4-year group, that the average symptom scores before immunotherapy, at the completion of immunotherapy, and at present were 8.48, 2.96, and 3.97, respectively. The second group's scores for these time periods were 8.26, 2.94, and 3.95, respectively.



SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

Pharmacy Times Strategic Alliance
 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.